Capnography is the measurement of carbon dioxide (CO2) concentrations or partial pressures in the breathing gases. Its primary application has been as a monitoring device for use in anaesthesia and intensive care.
It’s frequently shown as a graph of expiratory CO2 (measured in millimetres of mercury, “mmHg”) vs. time, or, less commonly, but more usefully, expired volume. When rebreathing systems are employed, the plot may additionally display the carbon dioxide that has been inspired.
The noninvasive measurement of the partial pressure of carbon dioxide (CO2) in exhaled breath expressed as the CO2 concentration over time is known as capnography. The carbon dioxide waveform, also known as a capnogram, graphically depicts the relationship between CO2 concentration and time.
The Europe Capnography Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
The LifeSense capnograph/pulse oximeter has been approved by the US Food and Drug Administration (FDA). LifeSense combines capnography and pulse oximetry into a single instrument that is simple to use.
Nonin, who has over 20 years of medical device success with breakthroughs like the Onyx fingertip and the Avant 4000 Bluetooth pulse oximeters, expects the portable gadget to be an industry leader.
The WIDESCREEN LCD display, mobility, and light weight are all key advantages of LifeSense. Despite the fact that capnography is a more complicated technology, Nonin has made it simple for everyone to operate the gadget.
The LifeSense capnography, like Nonin oximeters, is equipped with Nonin’s patented PureSAT technology. PureSAT allows for precise readings and quick responses.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.